drugset / Trial / NCT02935933

Paravertebral Morphine Versus Dexmedetomidine on Acute and Chronic Postmastectomy Pain

NCT02935933

Phase 1/2 Unknown 90 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluate the effect of addition of morphine, dexmedetomidine to bupivacaine in PVB could improve the analgesic effect and thus reduce postoperative morphine consumption and development of chronic neuropathic pain, compared to PVB with bupivacaine , in patients undergoing major breast cancer surgery, i.e., modified radical mastectomy (MRM) and breast conservation surgery with axillary lymph node dissection.

Timeline

Start
2016-10
Primary completion
2017-09
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 1 ug/kg Other
Comparator Morphine Other / unclassified 5 mg Other
Comparator Bupivacaine Other / unclassified 0.25 % Other
Comparator Bupivacaine Other / unclassified 20 ml Other

Indications